Publicacións en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (30)

2023

  1. Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs

    JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403

2022

  1. Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology

    Frontiers in immunology, Vol. 13, pp. 842354

2021

  1. Fewer COVID-19-associated strokes and reduced severity during the second COVID-19 wave: The Madrid Stroke Network

    European Journal of Neurology, Vol. 28, Núm. 12, pp. 4078-4089

  2. Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab

    Frontiers in Immunology, Vol. 12

  3. Stroke Acute Management and Outcomes During the COVID-19 Outbreak: A Cohort Study From the Madrid Stroke Network

    Stroke, Vol. 52, Núm. 2, pp. 552-562

  4. Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015

    European Neurology, Vol. 84, Núm. 1, pp. 16-21

2020

  1. Acute stroke care during the COVID-19 pandemic. Ictus Madrid Program recommendations

    Neurologia, Vol. 35, Núm. 4, pp. 258-263

  2. Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case–control study

    European Journal of Neurology, Vol. 27, Núm. 9, pp. 1738-1741

  3. Impact of the COVID-19 pandemic on the organisation of stroke care. Madrid Stroke Care Plan

    Neurologia, Vol. 35, Núm. 6, pp. 363-371

2019

  1. The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study

    European Journal of Neurology, Vol. 26, Núm. 2, pp. 230-237

2018

  1. Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC registry

    Neurologia, Vol. 33, Núm. 7, pp. 419-426

2017

  1. The Direct Referral to Endovascular Center criteria: a proposal for pre-hospital evaluation of acute stroke in the Madrid Stroke Network

    European Journal of Neurology, Vol. 24, Núm. 3, pp. 509-515

2016

  1. Réplica a la carta «Algunas consideraciones sobre el infarto cerebral desde otra óptica»

    Neurologia

2014

  1. Análisis de recursos asistenciales para el ictus en España en 2012: ¿beneficios de la Estrategia del Ictus del Sistema Nacional de Salud?

    Neurologia, Vol. 29, Núm. 7, pp. 387-396

  2. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

  3. How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up

    Journal of Neurology, Vol. 261, Núm. 8, pp. 1614-1621

2013

  1. Recurrent transient ischaemic attack and early risk of stroke: Data from the PROMAPA study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 84, Núm. 6, pp. 596-603

2012

  1. Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality?

    International Journal of Stroke, Vol. 7, Núm. 1, pp. 7-13

  2. Diabetes and previous stroke: Hazards for intravenous thrombolysis?

    European Journal of Neurology, Vol. 19, Núm. 4, pp. 587-593

  3. Efficacy of intravenous thrombolysis according to stroke subtypes: The Madrid Stroke Network data

    European Journal of Neurology, Vol. 19, Núm. 12, pp. 1568-1574